Parathyroid Diseases Enrolling by Invitation Phase 4 Trials for Ropivacaine (DB00296)

Also known as: Parathyroid Disease

IndicationStatusPhase
DBCOND0036113 (Parathyroid Diseases)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05294393Ropivacaine Plus Magnesium Sulphate InfiltrationSupportive Care